Inspired by the discovery that oligomers of cyclic β-
amino acids can adopt well-defined helical conformations,6,7
we previously developed a series of pyrrolidinyl PNA
with an R/β peptide backbone consisting of an alternat-
ing sequence of nucleobase-modified proline and cyclic
β-amino acid “spacer” such as 1-aminopyrrolidinecar-
boxylic acid (dapcPNA)8 or 2-aminocyclopentane-
carboxylic acid (acpcPNA).9 These pyrrolidinyl PNAs bind
to DNA with higher affinity and sequence specificity
compared to aegPNA.10 They also exhibited some un-
usual features, including the preference for binding to
DNA over RNA as well as the inability to form self-
hybrids. The failure of pyrrolidinyl PNA carrying acy-
clic spacers to recognize DNA/RNA targets11 suggested
that the cyclic five-membered ring spacer locks the con-
formation of the PNA into a form that is close to optimal
for DNA binding. The work carried out so far has been
limited to a five-membered ring spacer, and in order to
gain further insight into the structural properties of
these pyrrolidinyl PNA, an investigation of the effect
of the ring size of the spacer part was warranted.
Modification of the ring size should change both
the rigidity and the torsional angle (θ) of the NHꢀ
C2ꢀC1ꢀCO which is an integral part of the PNA
backbone7 and could in turn significantly affect the
hybridization properties of the resulting PNA.
which contains a 2-aminocyclopentanecarboxylic (ACPC)
spacer (Figure 1). Since the (1S,2S) configuration was
previously found to be optimal for the ACPC spacer,9
the same (1S,2S) configuration was a logical starting point
for the new ring systems. Thus, the Fmoc-derivative of
(1S,2S)-ACBC12 was prepared, along with the known
Fmoc-(1S,2S)-ACHC,13 and each of these derivatives
was combined with the (40R)-nucleobase-modified (20R)-
proline employing the Fmoc solid-phase peptide syn-
thesis previously developed14 to give eight new pyrrolidinyl
PNA sequences as shown in Table S1, Supporting Infor-
mation. All of these pyrrolidinyl PNA possess the same
(20R,40R) configuration at the proline part except for epi-
acbcPNA-sCom. This latter PNA, with a (20R,40S) config-
uration, was synthesized in order to investigate the self-pairing
abilities not observed in the (20R,40R) epimer of acpcPNA.15
The PNA was purified by HPLC (>90% purity), and the
identities confirmed by matrix-assisted laser desorption ioni-
zation time-of-flight (MALDI-TOF) mass spectrometry. It is
noteworthy that the intrinsically labile ACBC16 is compatible
with the basic conditions required during Fmoc group re-
moval and nucleobase side chain deprotection procedures.
Table 1. Thermal Stabilities of DNA and RNA Hybrids of
Homologous Pyrrolidinyl PNAa
entry
1
PNA
apDNA pDNA apRNA pRNA
acbcPNA-homoT
73.8
(72.5)
63.2
ꢀ
ꢀ
n.d.
ꢀ
n.d.
ꢀ
2
3
4
5
6
acbcPNA-mixAT
acbcPNA-mix
<20
(<20)
<20
(<20)
34.1
(<20)
ꢀ
50.8
(32.6)
58.2
(42.3)
62.9
(48.0)
n.d.
25.8
(<20)
31.7
(<20)
48.6
(32.9)
n.d.
ꢀ
(54.2)
66.1
(53.3)
69.8
acbcPNA-mixGC
achcPNA-homoT
achcPNA-mix
(54.5)
<20
(72.5)
<20
ꢀ
ꢀ
<20
(<20)
<20
<20
Figure 1. Structures and sequences of PNA.
(53.3)
(42.3)
(<20)
a Tm values of the corresponding acpcPNA hybrids under identical
conditions9 are shown in parentheses, and ap and p are antiparallel and
parallel, respectively. Conditions: 10 mM sodium phosphate buffer pH
7.0, 100 mM NaCl, and [PNA] = [DNA] = 1 μM. Tm values are
accurate to within (0.5 °C.
We now report on the behavior of two new PNA
manifolds, which incorporate 2-aminocyclobutane-
carboxylic acid (ACBC) or2-aminocyclohexanecarboxylic
acid (ACHC) spacers, referred to here as acbcPNA and
achcPNA respectively, and compare them with acpcPNA
The hybridization properties of acbcPNA-homoT and
achcPNA-homoT with cDNA (dA9) were investigated
by thermal denaturation experiments (monitored by
UVꢀvis at 260 nm) (Table 1, entries 1 and 5). A well-
defined thermal denaturation curve was observed only
with acbcPNA-homoT. The melting temperature (Tm) of
(6) (a) Appella, D. H.; Christianson, L. A.; Klein, D. A.; Powell,
D. R.; Huang, X.; Barchi, J. J., Jr.; Gellman, S. H. Nature 1997, 387,
381–382. (b) Cheng, R. P.; Gellman, S. H.; DeGrado, W. F. Chem. Rev.
2001, 101, 3219–3232.
(7) (a) Vasudev, P. G.; Chatterjee, S.; Shamala, N.; Balaram, P.
ꢀ
€ €
Chem. Rev. 2011, 111, 657–687. (b) Fulop, F.; Martinek, T. A.; Toth,
G. K. Chem. Soc. Rev. 2006, 35, 323–334.
(8) Vilaivan, T.; Lowe, G. J. Am. Chem. Soc. 2002, 124, 9326–9327.
(9) (a) Vilaivan, T.; Srisuwannaket, C. Org. Lett. 2006, 8, 1897–1900.
(b) Vilaivan, C.; Srisuwannaket, C.; Ananthanawat, C.; Suparpprom, C.;
Kawakami, J.; Yamaguchi, Y.; Tanaka, Y.; Vilaivan, T. Artif. DNA:
PNA XNA 2011, 2, 50–59.
(10) Ananthanawat, C.; Vilaivan, T.; Hoven, V. P.; Su, X. Biosens.
Bioelectron. 2010, 25, 1064–1069.
(11) (a) Vilaivan, T.; Suparpprom, C.; Harnyuttanakorn, P.; Lowe, G.
Tetrahedron Lett. 2001, 42, 5533–5536. (b) Vilaivan, T.; Suparpprom, C.;
Duanglaor, P.; Harnyuttanakorn, P.; Lowe, G. Tetrahedron Lett. 2003,
44, 1663–1666. (c) Ngamwiriyawong, P.; Vilaivan, T. Nucleosides,
Nucleotides Nucleic Acids 2011, 30, 97–112.
(12) (a) Fernandes, C.; Pereira, E.; Faure, S.; Aitken, D. J. J. Org.
Chem. 2009, 74, 3217–3220. (b) Declerck, V.; Aitken, D. J. Amino Acids
2011, 41, 587–595.
(13) (a) Schinnerl, M.; Murray, J. K.; Langenhan, J. M.; Gellman,
ꢂ
S. H. Eur. J. Org. Chem. 2003, 721–726. (b) Xu, D.; Prasad, K.; Repic, O.;
Blacklock, T. J. Tetrahedron: Asymmetry 1997, 8, 1445–1451.
(14) Lowe, G.; Vilaivan, T. J. Chem. Soc., Perkin Trans. 1 1997, 555–560.
(15) Taechalertpaisarn, J.; Sriwarom, P.; Boonlua, C.; Yotapan, N.;
Vilaivan, C.; Vilaivan, T. Tetrahedron Lett. 2010, 51, 5822–5826.
(16) Aitken, D. J.; Gauzy, C.; Pereira, E. Tetrahedron Lett. 2004, 45,
2359–2361.
Org. Lett., Vol. 14, No. 6, 2012
1441